Momotow, J., Bühnen, I., Trautmann‐Grill, K., Kobbe, G., Hahn, D., Schroers, R., Heinrich, B., Gaska, T., Forstbauer, H., Schmidt, B., Boger, R., Hüttmann, A., Heil, G., Kraemer, D. M., Krüger, W., Zeremski, V., Grobe, N., Jentsch‐Ullrich, K., Griesinger, F., Fuchs, M., von Tresckow, B., Borchmann, P., Engert, A., & Bröckelmann, P. J. (2022). outcomes of anti‐programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group multicentre real‐world analysis. British journal of haematology, 198, 401–404. http://access.bl.uk/ark:/81055/vdc_100159488075.0x000062